Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75919142 | 7591914 | 2 | F | 201603 | 20160725 | 20100917 | 20160930 | PER | US-ASTRAZENECA-2010SE23832 | ASTRAZENECA | 789.00 | MON | F | Y | 0.00000 | 20160930 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75919142 | 7591914 | 1 | PS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | D | 20639 | PROLONGED-RELEASE TABLET | |||||||||
| 75919142 | 7591914 | 2 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 400.0MG UNKNOWN | D | 20639 | 400 | MG | FILM-COATED TABLET | ||||||
| 75919142 | 7591914 | 3 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 300.0MG UNKNOWN | D | 20639 | 300 | MG | PROLONGED-RELEASE TABLET | ||||||
| 75919142 | 7591914 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 75919142 | 7591914 | 5 | C | AMITIZA | LUBIPROSTONE | 1 | 0 | ||||||||||||
| 75919142 | 7591914 | 6 | C | LYNZESS | 2 | 0 | |||||||||||||
| 75919142 | 7591914 | 7 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 75919142 | 7591914 | 4 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 75919142 | 7591914 | Basedow's disease | |
| 75919142 | 7591914 | Diabetes mellitus | |
| 75919142 | 7591914 | Drug dose omission | |
| 75919142 | 7591914 | Drug hypersensitivity | |
| 75919142 | 7591914 | Drug ineffective | |
| 75919142 | 7591914 | Emotional disorder | |
| 75919142 | 7591914 | Insomnia | |
| 75919142 | 7591914 | Thyroid disorder | |
| 75919142 | 7591914 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 75919142 | 7591914 | 4 | 2002 | 0 |